Product Information
LANSOPRAZOLE DR 15 MG CAPSULE is a generic product labeled by BluePoint Laboratories, priced at $0.1474 per EA under NDC 68001011105. Its NADAC has been published 655 times since Mar 19, 2014.
FDA first approved this application on Oct 15, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001011105
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA091269FDA Approved
10/15/2010
TE Code
AB
On Market Since
12/1/2013
Pharmacological Classes
Price Statistics
The NADAC for LANSOPRAZOLE DR 15 MG CAPSULE has been published 655 times since Mar 19, 2014, and over the history we have for it it has declined 80.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1474 per EA |
|---|---|
| All-time high | $0.8847 (Feb 11, 2015) |
| All-time low | $0.1227 (Nov 20, 2024) |
| 52-week high | $0.1754 |
| 52-week low | $0.1470 |
| Median price | $0.3480 |
| Average price | $0.3881 |
| Largest weekly change | +44.5% (Jun 19, 2024) |
| Weeks tracked | 655 |
| Tracking since | Mar 19, 2014 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BluePoint Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
lansoprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LANSOPRAZOLE DR 15 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOLE DR 15 MG CAPSULE, manufactured by BluePoint Laboratories, is $0.1474 per EA (NDC 68001011105), effective Sep 30, 2026.
How has the price of LANSOPRAZOLE DR 15 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LANSOPRAZOLE DR 15 MG CAPSULE has declined 80.2%. It has been tracked across 655 weekly CMS publications since Mar 19, 2014.
What are the highest and lowest recorded NADAC prices for LANSOPRAZOLE DR 15 MG CAPSULE?
Since Mar 19, 2014, the NADAC for LANSOPRAZOLE DR 15 MG CAPSULE has ranged from a low of $0.1227 (Nov 20, 2024) to a high of $0.8847 (Feb 11, 2015), with a median of $0.3480 per EA.
Are there cheaper alternatives to LANSOPRAZOLE DR 15 MG CAPSULE?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LANSOPRAZOLE DR 15 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures LANSOPRAZOLE DR 15 MG CAPSULE?
LANSOPRAZOLE DR 15 MG CAPSULE (NDC 68001011105) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.